Foundation Medicine to Present at Cowen and Company’s 38th Annual Healthcare Conference
March 08 2018 - 6:30AM
Business Wire
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that
members of the company's management team will present at Cowen
& Company’s 38th Annual Healthcare Conference on Wednesday,
March 14, 2018, at 10:40 a.m. ET in Boston.
A live, listen-only webcast of the presentation may be accessed
by visiting the investors section of the company’s website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the presentation and will
be archived on the company's website for 90 days.
About Foundation Medicine
Foundation Medicine (NASDAQ:FMI) is a molecular information
company dedicated to a transformation in cancer care in which
treatment is informed by a deep understanding of the genomic
changes that contribute to each patient’s unique cancer. The
company offers a full suite of comprehensive genomic profiling
assays to identify the molecular alterations in a patient’s cancer
and match them with relevant targeted therapies, immunotherapies
and clinical trials. Foundation Medicine's molecular information
platform aims to improve day-to-day care for patients by serving
the needs of clinicians, academic researchers and drug developers
to help advance the science of molecular medicine in cancer. For
more information, please visit http://www.FoundationMedicine.com or
follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® is a registered trademark of Foundation
Medicine, Inc.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180308005414/en/
Foundation MedicineMedia:Lee-Ann Murphy,
617-245-3077pr@foundationmedicine.comorInvestors:Kimberly
Brown, 617-418-2215ir@foundationmedicine.com
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Jul 2023 to Jul 2024